Proteins tied to kidney failure: research could lead to predictive test for diabetics.
tumor necrosis factor tumor necrosis factor
n. Abbr. TNF
A protein that is produced in the presence of an endotoxin, especially by monocytes and macrophages, is able to attack and destroy tumor cells, and exacerbates chronic inflammatory diseases. , or TNF, receptors with elevated incidence of kidney disease up to 12 years later. The association showed up in patients with type 1 and type 2 diabetes type 2 diabetes
See diabetes mellitus. , the researchers report online January 19 in the Journal of the American Society of Nephrology.
Study leader Andrzej Krolewski, a kidney researcher at Harvard Medical School Harvard Medical School (HMS) is one of the graduate schools of Harvard University. It is a prestigious American medical school located in the Longwood Medical Area of the Mission Hill neighborhood of Boston, Massachusetts. and the Joslin Diabetes Center Joslin Diabetes Center is the world’s largest and most respected diabetes research center, diabetes clinic, and provider of diabetes education. It is located in the Longwood Medical and Academic Area in Boston, Massachusetts. in Boston, says the findings may ultimately improve care for at-risk diabetes patients. "The most immediate application," says study coauthor Monika Niewczas, a researcher also at Harvard and Joslin, "will be a diagnostic test that we hope would be available soon."
TNF receptors serve as docking stations on cells. When their counterpart protein latches onto the receptor, the signal produced by that binding can instruct a cell to trigger inflammation or to take on other duties. Some TNF receptors also roam free, showing up in the blood, a characteristic the scientists measured in the new studies.
"These are good pilot studies, very well conducted," says Sankar Navaneethan, a nephrologist at the Cleveland Clinic who wasn't involved in the new research. "But they need to be replicated in future studies before we can embark on using this biomarker for predicting these outcomes in patients."
In one study, the researchers tracked the health status of 410 people with type 2 diabetes beginning in the early 1990s. Patients provided initial blood samples followed by information on their health over the next eight to 12 years. By the end of the study's follow-up period, 54 percent of patients with high concentrations of TNF receptors at the outset had developed kidney failure and needed dialysis or a transplant. Only 3 percent of patients with low levels of TNF receptors had such problems. After accounting for differences among the patients, the high-receptor group was still about six times more prone to kidney failure, Niewczas says.
The other study included 628 patients with type 1 diabetes type 1 diabetes
See diabetes mellitus. , formerly called juvenile-onset diabetes. Over five to 12 years of follow-up, participants who had high TNF receptor levels at the start were three times as likely to develop chronic kidney disease Chronic kidney disease (CKD), also know as chronic renal disease, is a progressive loss of renal function over a period of months or years through five stages. Each stage is a progression through an abnormally low and progressively worse glomerular filtration rate, which is as those with low receptor levels.
The researchers "provide very solid statistical and epidemiological evidence" linking TNF receptor abundance with kidney damage, says Klaus Ley, a physician at the La Jolla Institute for Allergy and Immunology in California. "But we don't know why the receptor levels are increased in these patients. This is just the beginning of a very exciting story."
Kidney failure causes In 2008, 112,476 people in the United States began treatment for end-stage renal disease (causes shown below). Diabetes 44% High blood pressure 28% Other causes 19% Glomerular disease 7% Cystic kidney disease 2% SOURCE: NATIONAL KIDNEY AND UROLOGIC DISEASES INFORMATION CLEARINGHOUSE Note: Table made from pie chart.
|Printer friendly Cite/link Email Feedback|
|Title Annotation:||Body & Brain|
|Date:||Feb 11, 2012|
|Previous Article:||Cardiovascular omens little-known: many Europeans don't recognize signs of stroke, heart attack.|
|Next Article:||Science talent search picks top 40: Intel-sponsored competition drew more than 1,800 entries.|